pharmaand GmbH
4 products tracked · names used in filings: pharmaand GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Rubraca rucaparib | Authorised | 2018-05-23 |
| 🇪🇺 | Farydak panobinostat | Authorised | 2015-08-28 |
| 🇪🇺 | Emselex darifenacin hydrobromide | Authorised | 2004-10-22 |
| 🇪🇺 | Pegasys peginterferon alfa-2a | Authorised | 2002-06-20 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.